![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Ketoisocaproate and Related
-Keto Acid Anions
Institute of Pharmacology and Toxicology, Technical University of Braunschweig, Braunschweig, Germany (H.H., K.A.U., K.H., U.P.); and Federal Institute for Drugs and Medical Devices, Bonn, Germany (B.J.Z.)
-Ketoisocaproate directly inhibits the ATP-sensitive K+ channel (KATP channel) in pancreatic
-cells, but it is unknown whether direct KATP channel inhibition contributes to insulin release by
-ketoisocaproate and related
-keto acid anions, which are generally believed to act via
-cell metabolism. In membranes from HIT-T15
-cells and COS-1 cells expressing sulfonylurea receptor 1,
-keto acid anions bound to the sulfonylurea receptor site of the KATP channel with affinities increasing in the order
-ketoisovalerate <
-ketovalerate <
-ketoisocaproate <
-ketocaproate <
-phenylpyruvate. Patch-clamp experiments revealed a similar order for the KATP channel-inhibitory potencies of the compounds (applied at the cytoplasmic side of inside-out patches from mouse
-cells). These findings were compared with the insulin secretion stimulated in isolated mouse islets by
-keto acid anions (10 mM). When all KATP channels were closed by the sulfonylurea glipizide,
-keto acid anions amplified the insulin release in the order
-phenylpyruvate <
-ketoisovalerate <
-ketovalerate
-ketocaproate <
-ketoisocaproate. The differences in amplification apparently reflected special features of the metabolism of the individual
-keto acid anions. In islets with active KATP channels, the first peak of insulin secretion triggered by
-keto acid anions was similar for
-ketoisocaproate,
-ketocaproate, and
-phenylpyruvate but lower for
-ketovalerate and insignificant for
-ketoisovalerate. This difference from the above orders indicates that direct KATP channel inhibition is not involved in the secretory responses to
-ketoisovalerate and
-ketovalerate, moderately contributes to initiation of insulin secretion by
-ketoisocaproate and
-ketocaproate, and is a major component of the insulin-releasing property of
-phenylpyruvate.
Address correspondence to: Dr. Uwe Panten, Institute of Pharmacology and Toxicology, Technical University of Braunschweig, Mendelssohnstrasse 1, D-38106 Braunschweig, Germany. E-mail: u.panten{at}tu-bs.de
This article has been cited by other articles:
![]() |
P. Newsholme, L. Brennan, and K. Bender Amino Acid Metabolism, {beta}-Cell Function, and Diabetes Diabetes, December 1, 2006; 55(Supplement_2): S39 - S47. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Tarasov, H. J. Welters, S. Senkel, G. U. Ryffel, A. T. Hattersley, N. G. Morgan, and F. M. Ashcroft A Kir6.2 Mutation Causing Neonatal Diabetes Impairs Electrical Activity and Insulin Secretion From INS-1 {beta}-Cells Diabetes, November 1, 2006; 55(11): 3075 - 3082. [Abstract] [Full Text] [PDF] |
||||